Immunohistochemical double- hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

查看全文 作　　者：Green TM; Young KH; Visco C; 出　　处：《J Clin Oncol》索引2012年第30卷第28期,共0页